Neuroprotective effects of the Alzheimer's disease-related gene seladin-1

Journal of Molecular Endocrinology

Volumn 41, Issue 5-6, 2008, Pages 251-261

  Peri, Alessandro ^a   Serio, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; AMYLOID BETA PROTEIN; CASPASE 3; CHOLESTEROL; DESMOSTEROL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; OXIDOREDUCTASE; PLACEBO; RALOXIFENE; SELADIN 1; SOMATOMEDIN C; TAMOXIFEN; THYROID HORMONE; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; APOPTOSIS; BRAIN DEVELOPMENT; BRAIN REGION; CELL PROLIFERATION; CHOLESTEROL SYNTHESIS; CLINICAL TRIAL; COGNITIVE DEFECT; DISEASE ASSOCIATION; DOWN REGULATION; DRUG DOSE COMPARISON; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE IDENTIFICATION; HISTOPATHOLOGY; HUMAN; INHIBITION KINETICS; NERVE CELL; NEUROPROTECTION; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CELL SURVIVAL; CHOLESTEROL; ESTRADIOL; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; RECEPTORS, ESTROGEN; SQUALENE; THYROID HORMONES;

EID: 57749083174     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/JME-08-0071     Document Type: Review

References (75)

1. Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, Delacourte A, Dingwall C, De Strooper B & Dotti CG 2004 Neuronal membrane cholesterol loss enhances amyloid peptide generation. Journal of Cell Biology 167 953-960.
2. Arispe N & Doh M 2002 Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides. FASEB Journal 16 1526-1536.
3. Barni T, Maggi M, Fantoni G, Granchi S, Mancina R, Gulisano M, Marra F, Macorsini E, Luconi M, Rotella C et al. 1999 Sex steroids and odorants modulate gonadotropin-releasing hormone secretion in primary cultures of human olfactory cells. Journal of Clinical Endocrinology and Metabolism 84 4266-4273.
4. Battista MC, Roberge C, Otis M & Gallo-Payet N 2007 Seladin-1 expression in rat adrenal gland: effect of adrenocorticotropic hormone treatment. Journal of Endocrinology 192 53-66.
5. Behl C 2003 Estrogen can protect neurons: modes of action. Journal of Steroid Biochemistry and Molecular Biology 83 195-197.
6. Benvenuti S, Luciani P, Vannelli GB, Gelmini S, Serio M & Peri A 2005 Estrogen and SERMs exert neuroprotective effects and stimulate the expression of selective Alzheimers disease indicator-1, a recently discovered anti-apoptotic gene, in human neuroblast long-term cell cultures. Journal of Clinical Endocrinology and Metabolism 90 1775-1782.
7. Benvenuti S, Saccardi R, Luciani P, Urbani S, Deledda C, Cellai I, Francini F, Squecco R, Rosati F, Danza G et al. 2006 Neuronal differentiation of human mesenchymal stem cells: changes in the expression of the Alzheimers disease - related gene seladin-1. Experimental Cell Research 312 2592-2604.
8. Benvenuti S, Luciani P, Cellai I, Deledda C, Baglioni S, Saccaridi R, Urbani S, Francini F, Squecco R, Giuliani C et al. 2008 Thyroid hormones promote cell differentiation and up-regulate the expression of the seladin-1 gene in in vitro models of human neuronal precursors. Journal of Endocrinology 197 437-446.
9. Biancolella M, Valentini A, Minella D, Secchione L, D'Amico F, Chillemi G, Gravina P, Bueno S, Prosperino G, Desideri A et al. 2007 Effects of dutasteride on the expression of genes related to androgen metabolism and related pathway in human prostate cancer cell lines. Investigational New Drugs 25 491-497.
10. Bonaccorsi L, Luciani P, Nesi G, Mannucci E, Deledda C, Dichiara F, Paglierini M, Rosati F, Masieri L, Serni S et al. 2008 Androgen receptor regulation of the seladin-1/DHCR24 gene: altered expression in prostate cancer. Laboratory Investigation 88 1049-1056.
11. Brooker GJ, Kalloniatis M, Russo VC, Murphy M, Werther GA & Bartlett PF 2000 Endogenous IGF-I regulates the neuronal differentiation of adult stem cells. Journal of Neuroscience Research 59 332-341.
12. Calzà L, Giardino L & Aloe L 1997 Thyroid hormone regulates NGF content and p75LNGFR expression in the basal forebrain of adult rats. Experimental Neurology 143 196-206.
13. Cecchi C, Rosati F, Pensalfini A, Formigli L, Nosi D, Liguri G, Dichiara F, Morello M, Danza G, Pieraccini G et al. 2008 Seladin-1/DHCR24 protects neuroblastoma cells against abeta toxicity by increasing membrane cholesterol content. Journal of Cellular and Molecular Medicine.
14. Clouse SD & Sasse JM 1998 BRASSINOSTEROIDS: essential regulators of plant growth and development. Annual Review of Plant Physiology and Plant Molecular Biology 49 427-451.
15. Crameri A, Biondi E, Kuehnle K, Lütjohann D, Thelen KM, Perga S, Dotti CG, Nitsch RM, Ledesma MD & Mohajeri MH 2006 The role of seladin-1/ DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. EMBO Journal 25 432-443.
16. Dhandapani KM & Brann DW 2002 Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biology of Reproduction 67 1379-1385.
17. Dong Y, Zhang H, Gao AC, Marshall JR & Ip C 2005 Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers. Molecular Cancer Therapeutics 4 1047-1055.
18. Fillit HM 2002 The role of hormone replacement therapy in the prevention of Alzheimer's disease. Archives of Internal Medicine 162 1934-1942.
19. FitzPatrick DR, Keeling JW, Evans MJ, Ran AE, Bell JE, Porteous ME, Mills K, Winter RM & Clayton PT 1998 Clinical phenotype of desmosterolosis. American Journal of Medical Genetics 75 145-152.
20. Fuller PJ, Alexiadis M, Jobling T & McNeilage J 2005 Seladin-1/DHCR24 expression in normal ovary, ovarian epithelial and granulosa tumours. Clinical Endocrinology 63 111-115.
21. Giannini S, Benvenuti S, Luciani P, Manuelli C, Cellai I, Deledda C, Pezzatini A, Vannelli GB, Maneschi E, Rotella CM et al. 2008 Intermittent high glucose concentrations reduce neuronal precursor survival by altering the IGF system: the involvement of the neuroprotective factor seladin-1. Journal of Endocrinology 198 523-532.
22. Greeve I, Hermans-Borgmeyer I, Brellinger C, Rasper D, Gomez-Isla T, Behl C, Levkau B & Nitsch RM 2000 The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. Journal of Neuroscience 20 7343-7352.
23. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Hermos RJ, Waisbren SE et al. 1999 Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. New England Journal of Medicine 341 549-555.
24. Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J & Jenster G 2006 Evolution of the androgen receptor pathway during progression of prostate cancer. Cancer Research 66 5012-5020.
25. Herman GE 2003 Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes. Human Molecular Genetics 12 R75-R88.
26. Iivonen S, Hiltunen M, Alafuzoff I, Mannermaa A, Kerokoski P, Puoliväli J, Salminen A, Helisalmi S & Soininen H 2002 Seladin-1 transcription is linked to neuronal degeneration in Alzheimer's disease. Neuroscience 113 301-310.
27. Klahre U, Noguchi T, Fujioka S, Takatsuto S, Yokta T, Nomura T, Yoshida S & Chua NH 1998 The Arabidopsis DIMINUTO/DWARF1 gene encodes a protein involved in steroid synthesis. Plant Cell 10 1677-1690.
28. König S & Neto VM 2002 Thyroid hormone actions on neural cells. Cellular and Molecular Neurobiology 22 517-544.
29. Kuehnle K, Crameri A, Kälin RE, Luciani P, Benvenuti S, Peri A, Ratti F, Rodolfo M, Kulic L, Heppner FL et al. 2008 Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress. Molecular and Cellular Biology 28 539-550.
30. Lavado-Autric R, Auso E, Garcia-Velasco JV, del Carmen Arufe M, Escobar del Rey F, Berbel P & Morreale de Escobar G 2003 Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. Journal of Clinical Investigation 111 1073-1082.
31. Lu X, Kambe F, Cao X, Kozaki Y, Kaji T, Ishii T & Seo H 2008 DHCR24 is a hydrogen peroxide scavenger, protecting cells from oxidative-stress-induced apoptosis. Endocrinology 149 3267-3273.
32. Luciani P, Ferruzzi P, Arnaldi G, Crescioli C, Benvenuti S, Valeri A, Greeve I, Serio M, Mannelli M & Peri A 2004 Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. Journal of Clinical Endocrinology and Metabolism 89 1332-1339.
33. Luciani P, Gelmini S, Ferrante E, Lania A, Benvenuti S, Baglioni S, Mantovani G, Cellai I, Ammannati F, Spada A et al. 2005 Expression of the antiapoptotic gene seladin-1 and octreotide-induced apoptosis in growth hormone-secreting and nonfunctioning pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 90 6156-6161.
34. Luciani P, Deledda C, Rosati F, Benvenuti S, Cellai I, Dichiara F, Morello M, Vannelli GB, Danza G, Serio M et al. 2008 Seladin-1 is a fundamental mediator of the neuroprotective effects of estrogen in human neuroblast long-term cell cultures. Endocrinology 149 4256-4266.
35. MacLusky NJ 2004 Estrogen and Alzheimer's disease: the apolipoprotein connection. Endocrinology 145 3062-3064.
36. Maggi A, Ciana P, Belcredito S & Vegeto E 2004 Estrogens in the nervous system: mechanisms and nonreproductive functions. Annual Review of Physiology 66 291-313.
37. Matthews CC & Feldman EL 1996 Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. Journal of Cellular Physiology 166 323-331.
38. Mazerbourg S, Callebaut I, Zapf J, Mohan S, Overgaard M & Monget P 2004 Up date on IGFBP4: regulation of IGFBP4 levels and functions, in vitro and in vivo. Growth Hormone and IGF Research 14 71-84.
39. Mendez P, Azcoitia I & Garcia-Segura LM 2005 Interdependence of oestrogen and insulin-like growth factor-I in the brain: potential for analyzing neuroprotective mechanisms. Journal of Endocrinology 185 11-17.
40. Mendez P, Wandosell F & Garcia-Segura LM 2006 Cross-talk between estrogen receptors and insulin-like growth factor-I receptor in the brain: cellular and molecular mechanisms. Frontiers in Neuroendocrinology 27 391-403.
41. Mirza R, Hayasaka S, Takagishi Y, Kambe F, Ohmori S, Maki K. Yamamoto M, Murakami K, Kaji T, Zadworny D et al. 2006 DHCR24 gene knockout mice demonstrate lethal dermopathy with differentiation and maturation defects in the epidermis. Journal of Investigative Dermatology 126 638-647.
42. Mirza R, Hayasaka S, Kambe F, Maki K, Kaji T, Murata Y & Seo H 2008 Increased expression of aquaporin-3 in the epidermis of DHCR24 knockout mice. British Journal of Dermatology 158 679-684.
43. Morreale de Escobar G, Obregón MJ & Escobar del Rey F 2004 Role of thyroid hormone during early brain development. European Journal of Endocrinology 151 U25-U37.
44. O'Neill K, Chen S & Brinton RD 2004a Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease. Experimental Neurology 185 63-80.
45. O'Neill K, Chen S & Brinton RD 2004b Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer's disease. Experimental Neurology 188 268-278.
46. Paganini-Hill A & Henderson VW 1994 Estrogen deficiency and risk of Alzheimer's disease in women. American Journal of Epidemiology 140 256-261.
47. Patel AJ, Hayashi M & Hunt A 1987 Selective persistent reduction in choline acetyltransferase activity in basal forebrain of the rat after thyroid deficiency during early life. Brain Research 422 182-185.
48. Peri A, Danza G & Serio H 2005 Seladin-1 as a target of estrogen receptor activation in the brain: a new gene for a rather old story? Journal of Endocrinological Investigation 28 285-295.
49. Piconi L, Quagliaro L, Assaloni R, Da Ros R, Maier A, Zuodar G & Ceriello A 2006 Constant and intermittent high glucose enhances endothelial cells apoptosis through mitocondrial superoxide over-production. Diabetes/Metabolism Research and Reviews 22 198-203.
50. Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL & de Vijlder JJ 2003 Maternal hypothyroxinemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clinical Endocrinology 59 282-288.
51. Puglielli L, Tanzi RE & Kovacs DM 2003 Alzheimer's disease: the cholesterol connection. Nature Neuroscience 6 345-351.
52. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J et al. 2003 Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. Journal of the American Medical Association 289 2663-2672.
53. Reiss AB, Siller KA, Rahman MM, Chan ES, Ghiso J & de Leon MJ 2004 Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease. Neurobiology of Aging 25 977-989.
54. Resnick SM & Henderson VW 2002 Hormone therapy and risk of Alzheimer disease. Journal of the American Medical Association 288 2170-2172.
55. Russo VC, Kobayashi K, Najdovska S, Baker NL & Werther GA 2004 Neuronal protection from glucose deprivation via modulation of glucose transport and inhibition of apoptosis: a role for the insulin-like growth factor system. Brain Research 1009 40-53.
56. Russo VC, Gluckman PD, Feldman EL & Werther GA 2005 The Insulin-like growth factor system and its pleiotropic functions in brain. Endocrine Reviews 26 916-943.
57. Sanchez-Ramos JR 2002 Neural cells derived from adult bone marrow and umbilical cord blood. Journal of Neuroscience Research 69 880-893.
58. Santisteban P & Bernal J 2005 Thyroid development and effect on the nervous system. Reviews in Endocrine and Metabolic Disorders 6 217-228.
59. Sarkar D, Imai T, Kambe F, Shibata A, Ohmori S, Siddiq A, Hayasaka S, Funahashi H & Seo H 2001 The human homolog of Diminuto/Dwarf1 gene (hDiminuto): a novel ACTH-responsive gene over-expressed in benign cortisol-producing adrenocortical adenomas. Journal of Clinical Endocrinology and Metabolism 86 5130-5137.
60. Schumacher M, Guennoun R, Ghoumari A, Massaad C, Robert F, El-Etr M, Akwa Y, Rajkowski K & Baulieu EE 2007 Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocrine Reviews 28 387-439.
61. Selkoe DJ 2001 Alzheimer's disease: genes, proteins, and therapy. Physiological Reviews 81 741-776.
62. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN III, Assaf AR, Jackson RD et al. 2003 Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in post-menopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. Journal of the American Medical Association 289 2651-2662.
63. Di Stasi D, Vallacchi V, Campi V, Ranzani T, Daniotti M, Chiodini E, Fiorentini S, Greeve I, Prinetti A, Rivoltini L et al. 2003 DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis. International Journal of Cancer 115 224-230.
64. Takahashi T, Gasch A, Nishizawa N & Chua NH 1995 The DIMINUTO gene of Arabidopsis is involved in regulating cell elongation. Genes and Development 9 97-107.
65. Tomlinson DR & Gardiner NJ 2008 Glucose neurotoxicity. Nature Reviews. Neuroscience 9 36-45.
66. Turgeon JL, Carr MC, Maki PM, Mendelsohn ME & Wise P 2006 Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocrine Reviews 27 576-605.
67. Vannelli GB, Ensoli F, Zonefrati K, Kubota Y, Arcangeli A, Becchetti A, Camici G, Barni T, Thiele CJ & Balboni GC 1995 Neuroblast long-term cell cultures from human fetal olfactory epithelium respond to odors. Journal of Neuroscience 15 4282-4294.
68. Waterham HR, Koster J, Romeijn GJ, Hennekam RC, Vreken P, Andersson HC, FitzPatrick DR, Kelley RI & Wanders RJ 2001 Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. American Journal of Human Genetics 69 685-694.
69. Wechsler A, Brafman A, Shafir M, Heverin M, Gottlieb H, Damari G, Gozlan-Kelner S, Spivak I, Moshkin O, Fridman E et al. 2003 Generation of viable cholesterol-free mice. Science 302 2087.
70. Woodbury D, Schwarz EJ, Prockop DJ & Black IB 2000 Adult rat and human bone marrow stromal cells differentiate into neurons. Journal of Neuroscience Research 61 364-370.
71. Wu C, Miloslavskaya I, Demontis S, Maestro R & Galaktionov K 2004 Regulation of cellular response to oncogenic and oxidative stress by Seladin-1. Nature 432 640-645.
72. Yaffe K, Krueger K, Cummings SR, Blackwell T, Henderson VW, Sarkar S, Ensrud K & Grady D 2005 Effect of raloxifene on prevention of dementia and cognitive imparirment in older women: the Multiple Outcome of Raloxifene Evaluation (MORE) randomized trial. American Journal of Psychiatry 162 685-690.
73. Yanagisawa K 2002 Cholesterol and pathological processes in Alzheimer's disease. Journal of Neuroscience Research 70 361-366.
74. Yao JK, Wengenack TM, Curran GL & Poduslo JF 2008 Reduced membrane lipids in the cortex of Alzheimer's disease transgenic mice. Neurochemical Research. In Press.
75. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC & Cache County Memory Study Investigators 2002 Hormone replacement therapy and incidence of Alzheimer disease in older women. Journal of the American Medical Association 288 2123-2129.